Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Emergent Biosolutions (EBS)

Emergent Biosolutions (EBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 588,980
  • Shares Outstanding, K 54,184
  • Annual Sales, $ 1,049 M
  • Annual Income, $ -760,500 K
  • EBIT $ -78 M
  • EBITDA $ 287 M
  • 60-Month Beta 1.60
  • Price/Sales 0.52
  • Price/Cash Flow 11.63
  • Price/Book 1.09

Options Overview Details

View History
  • Implied Volatility 76.49% ( +9.84%)
  • Historical Volatility 57.71%
  • IV Percentile 6%
  • IV Rank 7.59%
  • IV High 505.77% on 02/07/24
  • IV Low 41.21% on 09/11/24
  • Put/Call Vol Ratio 0.21
  • Today's Volume 349
  • Volume Avg (30-Day) 720
  • Put/Call OI Ratio 0.22
  • Today's Open Interest 13,850
  • Open Int (30-Day) 13,277

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.35
  • Number of Estimates 1
  • High Estimate -0.35
  • Low Estimate -0.35
  • Prior Year -0.77
  • Growth Rate Est. (year over year) +54.55%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.95 +41.93%
on 12/27/24
11.49 -1.80%
on 01/23/25
+3.13 (+38.45%)
since 12/23/24
3-Month
7.70 +46.54%
on 12/20/24
12.73 -11.36%
on 11/07/24
+2.53 (+28.95%)
since 10/23/24
52-Week
1.42 +694.61%
on 02/06/24
15.10 -25.27%
on 07/30/24
+9.31 (+472.77%)
since 01/23/24

Most Recent Stories

More News
Enrollment Starts in Africa CDC-Led MpOx Therapeutic Study (MOSA)

EBS : 11.33 (+4.23%)
Emergent BioSolutions Gains Exclusive Commercial Rights to KLOXXADO® (naloxone HCI) Nasal Spray from Hikma Pharmaceuticals

EBS : 11.33 (+4.23%)
Emergent BioSolutions Receives Contract Option Valued at Approximately $16.7 Million to Continue Development Collaboration with BARDA on Ebangaâ„¢ (ansuvimab-zykl) Treatment for Ebola

EBS : 11.33 (+4.23%)
Emergent BioSolutions to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025

EBS : 11.33 (+4.23%)
Emergent BioSolutions Announces Exercise of $20 Million Option to Supply U.S. Department of Defense with BioThrax® (Anthrax Vaccine Adsorbed)

EBS : 11.33 (+4.23%)
Why Emergent BioSolutions Stock Blasted Higher Today

An analyst initiated coverage of Emergent BioSolutions (NYSE: EBS) stock as the last trading week of 2024 kicked off, and investors reacted quite positively to the move. On the news, they piled into the...

$SPX : 6,098.82 (+0.20%)
EBS : 11.33 (+4.23%)
Emergent BioSolutions Receives $50 Million Contract Option from BARDA to Procure Doses of CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted)

EBS : 11.33 (+4.23%)
Why Emergent BioSciences Stock Plummeted Today

Emergent BioSolutions (NYSE: EBS) saw its shares tumble on Tuesday, due to news of a share sell-off. The vaccine maker divulged in a regulatory filing that several institutional share and warrant holders...

$SPX : 6,098.82 (+0.20%)
EBS : 11.33 (+4.23%)
GeoVax, SIGA Jump After WHO Extends Mpox Public Emergency Status: Here’s What Retail Thinks

Emergent Biosolutions and Chimerix also saw marginal gains after the announcement.

SIGA : 6.46 (+1.10%)
EBS : 11.33 (+4.23%)
GOVX : 2.11 (unch)
CMRX : 3.85 (+1.85%)
10 Stocks Retailers On Stocktwits Are Most Bullish/Bearish About To Start The Week

As the new week unfolds, earnings and economic data will again dictate sentiment.

MARA : 20.11 (+2.13%)
BLK : 1,011.68 (+0.53%)
NFLX : 973.73 (+2.07%)
PDD : 102.91 (-0.16%)
AUPH : 7.90 (+2.20%)
CKPT : 2.91 (+5.05%)
EVH : 9.94 (-0.60%)
EBS : 11.33 (+4.23%)
BIDU : 82.29 (-0.86%)
SPY : 608.08 (+0.27%)
COIN : 300.28 (+1.50%)

Business Summary

Emergent BioSolutions, Inc. is a global specialty biopharmaceutical company offering specialized products to health care providers and governments to combat emerging public health threats. It also supplies vaccines to domestic and international non-government organizations and governments in/ outside...

See More

Key Turning Points

3rd Resistance Point 12.13
2nd Resistance Point 11.58
1st Resistance Point 11.23
Last Price 11.33
1st Support Level 10.33
2nd Support Level 9.78
3rd Support Level 9.43

See More

52-Week High 15.10
Last Price 11.33
Fibonacci 61.8% 9.87
Fibonacci 50% 8.26
Fibonacci 38.2% 6.65
52-Week Low 1.42

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar